US Bancorp’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94K | Sell |
259
-10,963
| -98% | -$124K | ﹤0.01% | 3776 |
|
|
2025
Q1 | $74.6K | Buy |
11,222
+11,108
| +9,744% | +$73.9K | ﹤0.01% | 2534 |
|
|
2024
Q4 | $1.26K | Sell |
114
-70
| -38% | -$772 | ﹤0.01% | 3924 |
|
|
2024
Q3 | $2.26K | Sell |
184
-212
| -54% | -$2.61K | ﹤0.01% | 3746 |
|
|
2024
Q2 | $5.35K | Buy |
+396
| New | +$5.35K | ﹤0.01% | 3474 |
|
|
2023
Q4 | – | Sell |
-538
| Closed | -$2.12K | – | 4110 |
|
|
2023
Q3 | $2.12K | Sell |
538
-283
| -34% | -$1.12K | ﹤0.01% | 3625 |
|
|
2023
Q2 | $8.73K | Sell |
821
-80
| -9% | -$850 | ﹤0.01% | 3282 |
|
|
2023
Q1 | $7.51K | Buy |
901
+410
| +84% | +$3.42K | ﹤0.01% | 3372 |
|
|
2022
Q4 | $4.53K | Sell |
491
-944
| -66% | -$8.71K | ﹤0.01% | 3527 |
|
|
2022
Q3 | $18K | Sell |
1,435
-79
| -5% | -$991 | ﹤0.01% | 3068 |
|
|
2022
Q2 | $20K | Buy |
1,514
+1,151
| +317% | +$15.2K | ﹤0.01% | 3039 |
|
|
2022
Q1 | $8K | Buy |
363
+242
| +200% | +$5.33K | ﹤0.01% | 3450 |
|
|
2021
Q4 | $3K | Buy |
+121
| New | +$3K | ﹤0.01% | 3798 |
|
|
2020
Q4 | – | Sell |
-600
| Closed | -$20K | – | 3803 |
|
|
2020
Q3 | $20K | Hold |
600
| – | – | ﹤0.01% | 2779 |
|
|
2020
Q2 | $14K | Hold |
600
| – | – | ﹤0.01% | 2921 |
|
|
2020
Q1 | $14K | Buy |
+600
| New | +$14K | ﹤0.01% | 2846 |
|